FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2129570557> ?p ?o ?g. }

• W2129570557 endingPage "2379" @default.
• W2129570557 startingPage "2373" @default.
• W2129570557 abstract "Abstract Purpose: Melanin has emerged as an attractive target for radioimmunotherapy (RIT) of melanoma, and a radiolabeled monoclonal antibody (mAb) 6D2 to melanin is currently in clinical evaluation. We investigated two approaches to improve the targeting of radiation to tumors using melanin-binding mAbs: (a) the use of an additional mAb to melanin could provide information on whether using antibodies to melanin can serve as a general approach to development of therapeutics for melanoma, and (b) as melanin targeting involves the antibody binding to extracellular melanin released from necrotic melanoma cells, we hypothesized that the administration of a chemotherapeutic agent followed by RIT would facilitate the delivery of radiation to the tumors due to the increased presence of free melanin. Experimental Design: We evaluated the therapeutic efficacy of two melanin-binding IgM mAbs labeled with 188Re (6D2 and 11B11). We compared the efficacy of RIT with 188Re-6D2 to chemotherapy with dacarbazine (DTIC) and to combined chemotherapy and RIT in human metastatic melanoma-bearing nude mice. Results: Therapeutic efficacy of 188Re-labeled 6D2 and 11B11 was comparable despite differences in their affinity and binding site numbers. Comparison of chemotherapy with DTIC and RIT revealed that RIT was more effective in slowing tumor growth in mice. Administration of DTIC followed by RIT was more effective than either modality alone. Conclusions: These results provide encouragement for the development of RIT for melanoma with melanin-binding mAbs and suggest that combining chemotherapy and RIT may be a promising approach for the treatment of metastatic melanoma." @default.
• W2129570557 created "2016-06-24" @default.
• W2129570557 creator A5001312410 @default.
• W2129570557 creator A5002564042 @default.
• W2129570557 creator A5005930546 @default.
• W2129570557 creator A5021690730 @default.
• W2129570557 creator A5034610205 @default.
• W2129570557 creator A5043927831 @default.
• W2129570557 creator A5052585292 @default.
• W2129570557 creator A5077902719 @default.
• W2129570557 creator A5086358764 @default.
• W2129570557 date "2009-04-01" @default.
• W2129570557 modified "2023-10-14" @default.
• W2129570557 title "Radioimmunotherapy of Experimental Human Metastatic Melanoma with Melanin-Binding Antibodies and in Combination with Dacarbazine" @default.
• W2129570557 cites W1977294492 @default.
• W2129570557 cites W1991546979 @default.
• W2129570557 cites W1992567223 @default.
• W2129570557 cites W2001799342 @default.
• W2129570557 cites W2002861811 @default.
• W2129570557 cites W2032759558 @default.
• W2129570557 cites W2034924732 @default.
• W2129570557 cites W2046697210 @default.
• W2129570557 cites W2056014805 @default.
• W2129570557 cites W2058426435 @default.
• W2129570557 cites W2064226066 @default.
• W2129570557 cites W2069676587 @default.
• W2129570557 cites W2115535209 @default.
• W2129570557 cites W2151396669 @default.
• W2129570557 cites W2163378683 @default.
• W2129570557 cites W2169147691 @default.
• W2129570557 cites W3192823395 @default.
• W2129570557 cites W4230922890 @default.
• W2129570557 doi "https://doi.org/10.1158/1078-0432.ccr-08-2376" @default.
• W2129570557 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19293257" @default.
• W2129570557 hasPublicationYear "2009" @default.
• W2129570557 type Work @default.
• W2129570557 sameAs 2129570557 @default.
• W2129570557 citedByCount "33" @default.
• W2129570557 countsByYear W21295705572012 @default.
• W2129570557 countsByYear W21295705572013 @default.
• W2129570557 countsByYear W21295705572014 @default.
• W2129570557 countsByYear W21295705572015 @default.
• W2129570557 countsByYear W21295705572016 @default.
• W2129570557 countsByYear W21295705572017 @default.
• W2129570557 countsByYear W21295705572019 @default.
• W2129570557 countsByYear W21295705572020 @default.
• W2129570557 countsByYear W21295705572021 @default.
• W2129570557 countsByYear W21295705572022 @default.
• W2129570557 crossrefType "journal-article" @default.
• W2129570557 hasAuthorship W2129570557A5001312410 @default.
• W2129570557 hasAuthorship W2129570557A5002564042 @default.
• W2129570557 hasAuthorship W2129570557A5005930546 @default.
• W2129570557 hasAuthorship W2129570557A5021690730 @default.
• W2129570557 hasAuthorship W2129570557A5034610205 @default.
• W2129570557 hasAuthorship W2129570557A5043927831 @default.
• W2129570557 hasAuthorship W2129570557A5052585292 @default.
• W2129570557 hasAuthorship W2129570557A5077902719 @default.
• W2129570557 hasAuthorship W2129570557A5086358764 @default.
• W2129570557 hasBestOaLocation W21295705571 @default.
• W2129570557 hasConcept C107538193 @default.
• W2129570557 hasConcept C126322002 @default.
• W2129570557 hasConcept C159654299 @default.
• W2129570557 hasConcept C185592680 @default.
• W2129570557 hasConcept C203014093 @default.
• W2129570557 hasConcept C2776146153 @default.
• W2129570557 hasConcept C2776694085 @default.
• W2129570557 hasConcept C2777658100 @default.
• W2129570557 hasConcept C2780964509 @default.
• W2129570557 hasConcept C502942594 @default.
• W2129570557 hasConcept C542903549 @default.
• W2129570557 hasConcept C55493867 @default.
• W2129570557 hasConcept C71924100 @default.
• W2129570557 hasConceptScore W2129570557C107538193 @default.
• W2129570557 hasConceptScore W2129570557C126322002 @default.
• W2129570557 hasConceptScore W2129570557C159654299 @default.
• W2129570557 hasConceptScore W2129570557C185592680 @default.
• W2129570557 hasConceptScore W2129570557C203014093 @default.
• W2129570557 hasConceptScore W2129570557C2776146153 @default.
• W2129570557 hasConceptScore W2129570557C2776694085 @default.
• W2129570557 hasConceptScore W2129570557C2777658100 @default.
• W2129570557 hasConceptScore W2129570557C2780964509 @default.
• W2129570557 hasConceptScore W2129570557C502942594 @default.
• W2129570557 hasConceptScore W2129570557C542903549 @default.
• W2129570557 hasConceptScore W2129570557C55493867 @default.
• W2129570557 hasConceptScore W2129570557C71924100 @default.
• W2129570557 hasIssue "7" @default.
• W2129570557 hasLocation W21295705571 @default.
• W2129570557 hasLocation W21295705572 @default.
• W2129570557 hasOpenAccess W2129570557 @default.
• W2129570557 hasPrimaryLocation W21295705571 @default.
• W2129570557 hasRelatedWork W1532568685 @default.
• W2129570557 hasRelatedWork W1787597555 @default.
• W2129570557 hasRelatedWork W2066978337 @default.
• W2129570557 hasRelatedWork W2129570557 @default.
• W2129570557 hasRelatedWork W2169294576 @default.
• W2129570557 hasRelatedWork W2386398244 @default.
• W2129570557 hasRelatedWork W2407024650 @default.
• W2129570557 hasRelatedWork W2945136554 @default.

• next